In the past few years, we’ve witnessed unprecedented policy and pricing reforms. Today they are creating seismic shifts for global market access. Decisions once treated as local or tactical now carry current and future global cross-portfolio consequences.
Net Price Governance Net price decisions made today determine 2026–2028 portfolio value. Organizations that govern net price proactively will protect launch integrity, preserve margin, and stabilize enterprise value.
Proliferation of non-traditional competitors and stakeholders, including non-traditional flow of innovation, and a general perception of inflated cost of healthcare, challenge the legacy model of drug development and commercialization.
Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals – one of the UK's biggest export categories – proved optimistic.